Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $43.19M in the quarter ending June 30, 2024, a decrease of -11.72%. This brings the company's revenue in the last twelve months to $168.77M, down -10.99% year-over-year. In the year 2023, Adaptive Biotechnologies had annual revenue of $170.28M, down -8.11%.

• Revenue (ttm): $168.77M
• Revenue Growth: -10.99%
• P/S Ratio: 4.08
• Revenue / Employee: $238,034
• Employees: 709
• Market Cap: 666.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	170.28M	-15.03M	-8.11%
Dec 31, 2022	185.31M	30.96M	20.06%
Dec 31, 2021	154.34M	55.96M	56.88%
Dec 31, 2020	98.38M	13.31M	15.65%
Dec 31, 2019	85.07M	29.41M	52.83%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.